Literature DB >> 32336723

Treatment of SARS-CoV-2: How far have we reached?

Waquar Ahsan1, Shamama Javed2, Mohammed Al Bratty1, Hassan A Alhazmi1,3, Asim Najmi1.   

Abstract

The virus severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is currently affecting more than 200 countries and territories worldwide. It has been declared as pandemic by World Health Organization (WHO) and the whole world is suffering from corona virus disease 2019 (COVID-19). Currently, no treatment for SARS-CoV-2 are approved because of lack of evidence, but a number of clinical trials are in process and we are expecting fruitful results very soon. This review focuses on various approaches of treatment and few of the most recent clinical trials carried out in this field.

Entities:  

Keywords:  SARS-CoV-2; antiviral; clinical trial; corona virus; pandemic

Mesh：

Substances：

Year:  2020        PMID： 32336723     DOI： 10.5582/ddt.2020.03008

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN： 1881-7831


  14 in total

1. 

Authors:  Stefan Dübel; Michael Hust; André Frenzel; Thomas Schirrmann
Journal:  Biospektrum (Heidelb)       Date:  2020-06-26

2.  Application of Sensitivity Analysis to Discover Potential Molecular Drug Targets.

Authors:  Malgorzata Kardynska; Jaroslaw Smieja; Pawel Paszek; Krzysztof Puszynski
Journal:  Int J Mol Sci       Date:  2022-06-13       Impact factor: 6.208

3.  Therapeutic agents tested in 238 COVID-19 hospitalized patients and their relationship with mortality.

Authors:  Mario Rivera-Izquierdo; María Del Carmen Valero-Ubierna; Juan Luis R-delAmo; Miguel Ángel Fernández-García; Silvia Martínez-Diz; Arezu Tahery-Mahmoud; Marta Rodríguez-Camacho; Ana Belén Gámiz-Molina; Nicolás Barba-Gyengo; Pablo Gámez-Baeza; Celia Cabrero-Rodríguez; Pedro Antonio Guirado-Ruiz; Divina Tatiana Martín-Romero; Antonio Jesús Láinez-Ramos-Bossini; María Rosa Sánchez-Pérez; José Mancera-Romero; Miguel García-Martín; Luis Miguel Martín-delosReyes; Virginia Martínez-Ruiz; Eladio Jiménez-Mejías
Journal:  Med Clin (Engl Ed)       Date:  2020-10-09

4.  A retrospective comparison of drugs against COVID-19.

Authors:  Jiahong Tan; Yuan Yuan; Cheng Xu; Chunyan Song; Dan Liu; Ding Ma; Qinglei Gao
Journal:  Virus Res       Date:  2020-12-14       Impact factor: 3.303

Review 5.  COVID-19 and Dentistry in 72 Questions: An Overview of the Literature.

Authors:  Stéphane Derruau; Jérôme Bouchet; Ali Nassif; Alexandre Baudet; Kazutoyo Yasukawa; Sandrine Lorimier; Isabelle Prêcheur; Agnès Bloch-Zupan; Bernard Pellat; Hélène Chardin; Sophie Jung
Journal:  J Clin Med       Date:  2021-02-16       Impact factor: 4.241

Review 6.  A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Reham N Elbendary; Fadiyah Ahmed Alharbi; Sultan Qalit Alhamrani; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-03-16       Impact factor: 4.219

Review 7.  Recent Advancements in the Diagnosis, Prevention, and Prospective Drug Therapy of COVID-19.

Authors:  Waquar Ahsan; Hassan A Alhazmi; Kuldeep Singh Patel; Bharti Mangla; Mohammed Al Bratty; Shamama Javed; Asim Najmi; Muhammad Hadi Sultan; Hafiz A Makeen; Asaad Khalid; Syam Mohan; Manal M E Taha; Shahnaz Sultana
Journal:  Front Public Health       Date:  2020-07-10

8.  Prediction of respiratory decompensation in Covid-19 patients using machine learning: The READY trial.

Authors:  Hoyt Burdick; Carson Lam; Samson Mataraso; Anna Siefkas; Gregory Braden; R Phillip Dellinger; Andrea McCoy; Jean-Louis Vincent; Abigail Green-Saxena; Gina Barnes; Jana Hoffman; Jacob Calvert; Emily Pellegrini; Ritankar Das
Journal:  Comput Biol Med       Date:  2020-08-06       Impact factor: 4.589

9.  Efficacy and safety of Lianhua Qingwen combined with conventional antiviral Western Medicine in the treatment of coronavirus disease (covid-19) in 2019: Protocol for a systematic review and meta-analysis.

Authors:  Xiaolin Zhang; Di Cao; Junnan Liu; Qi Zhang; Mingjun Liu
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

Review 10.  Snake venom-derived bradykinin-potentiating peptides: A promising therapy for COVID-19?

Authors:  Ahmed S Gouda; Bruno Mégarbane
Journal:  Drug Dev Res       Date:  2020-08-05       Impact factor: 5.004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.